Clinical Trial Update: INVESTIGATION of the EFFICACY and SAFETY of the DRUG "AS-PROBIONORM" [Phase 2]

View source ↗

Summary

Phase 2 trial of AS-PROBIONORM assessing efficacy and safety has completed, reporting on its effects for intestinal infections and dysbiosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysbiosis
• Intestinal Infections

Drugs mentioned

• AS-PROBIONORM

Snippet

Sponsor: Industrial Microbiology LLP | Conditions: Intestinal Infections, Dysbacteriosis | Phase 2 | Status: COMPLETED